EP1763356
Samsetning sem innifelur survívin andþætt fákirni og gemsitabín til meðhöndlunar á krabbameini.
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
15.4.2005EP published:
16.7.2008EP application number:
05738307.7
EP translation filed:
24.10.2008Grant published:
15.11.2008EPO information:
European Patent Register
Max expiry date:
14.4.2025Expiry date:
14.4.2013
Title:
COMPOSITION COMPRISING A SURVIVIN ANTISENSE OLIGONUCLEOTIDE AND GEMCITABINE FOR THE TREATMENT OF CANCER
Timeline
Today
15.4.2005EP application
16.7.2008EP Publication
24.10.2008Translation submitted
15.11.2008Registration published
14.4.2013Expires
Owner
Name:
ELI LILLY AND COMPANYAddress:
Lilly Corporate Center, Indianapolis, Indiana 46285, US
Inventor
Name:
PATEL, Bharvin, KumarAddress:
Westfield, IN 46074, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
564540 PDate:
22.4.2004Country:
US
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 20.4.2009
Expires: 30.4.2010
Payer:
Number: 6
Paid: 25.3.2010
Expires: 30.4.2011
Payer: Örn Þór, slf.
Number: 7
Paid: 18.3.2011
Expires: 14.4.2012
Payer: Örn Þór, slf.
Number: 8
Paid: 19.3.2012
Expires: 14.4.2013
Payer: Örn Þór, slf.